[Portal vein thrombosis in protein C deficiency: successful fibrinolytic therapy with ultra-high dose streptokinase]. 1994

D Jäger, and D Hüppe, and A Weber, and U Schwegler, and J Barth, and B E Braun
Abteilung für Kardiologie und Angiologie, Bergmannsheil, Universitätsklinik, Ruhr-Universität Bochum.

UI MeSH Term Description Entries
D008297 Male Males
D011169 Portal Vein A short thick vein formed by union of the superior mesenteric vein and the splenic vein. Portal Veins,Vein, Portal,Veins, Portal
D001780 Blood Coagulation Tests Laboratory tests for evaluating the individual's clotting mechanism. Coagulation Tests, Blood,Tests, Blood Coagulation,Blood Coagulation Test,Coagulation Test, Blood,Test, Blood Coagulation
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D013300 Streptokinase Streptococcal fibrinolysin . An enzyme produced by hemolytic streptococci. It hydrolyzes amide linkages and serves as an activator of plasminogen. It is used in thrombolytic therapy and is used also in mixtures with streptodornase (STREPTODORNASE AND STREPTOKINASE). EC 3.4.-. Avelizin,Awelysin,Celiase,Distreptase,Kabikinase,Kabivitrum,Streptase,Streptodecase
D013927 Thrombosis Formation and development of a thrombus or blood clot in BLOOD VESSELS. Atherothrombosis,Thrombus,Blood Clot,Blood Clots,Thromboses
D015912 Thrombolytic Therapy Use of infusions of FIBRINOLYTIC AGENTS to destroy or dissolve thrombi in blood vessels or bypass grafts. Fibrinolytic Therapy,Thrombolysis, Therapeutic,Therapeutic Thrombolysis,Therapy, Fibrinolytic,Therapy, Thrombolytic,Fibrinolytic Therapies,Therapeutic Thrombolyses,Therapies, Fibrinolytic,Therapies, Thrombolytic,Thrombolyses, Therapeutic,Thrombolytic Therapies
D020151 Protein C Deficiency An absence or deficiency in PROTEIN C which leads to impaired regulation of blood coagulation. It is associated with an increased risk of severe or premature thrombosis. (Stedman's Med. Dict., 26th ed.) Deficiency, Protein C,Hereditary Thrombophilia Due To Protein C Deficiency,Deficiencies, Protein C,Protein C Deficiencies

Related Publications

D Jäger, and D Hüppe, and A Weber, and U Schwegler, and J Barth, and B E Braun
April 1989, Medizinische Klinik (Munich, Germany : 1983),
D Jäger, and D Hüppe, and A Weber, and U Schwegler, and J Barth, and B E Braun
June 1991, Lancet (London, England),
D Jäger, and D Hüppe, and A Weber, and U Schwegler, and J Barth, and B E Braun
January 2023, Pediatrics international : official journal of the Japan Pediatric Society,
D Jäger, and D Hüppe, and A Weber, and U Schwegler, and J Barth, and B E Braun
January 1988, Folia haematologica (Leipzig, Germany : 1928),
D Jäger, and D Hüppe, and A Weber, and U Schwegler, and J Barth, and B E Braun
January 1988, Hepatology (Baltimore, Md.),
D Jäger, and D Hüppe, and A Weber, and U Schwegler, and J Barth, and B E Braun
January 1990, Acta medica portuguesa,
D Jäger, and D Hüppe, and A Weber, and U Schwegler, and J Barth, and B E Braun
June 1991, The Netherlands journal of medicine,
D Jäger, and D Hüppe, and A Weber, and U Schwegler, and J Barth, and B E Braun
January 1990, Gastroenterologie clinique et biologique,
D Jäger, and D Hüppe, and A Weber, and U Schwegler, and J Barth, and B E Braun
January 2007, Indian journal of dermatology, venereology and leprology,
D Jäger, and D Hüppe, and A Weber, and U Schwegler, and J Barth, and B E Braun
April 2021, West African journal of medicine,
Copied contents to your clipboard!